LBA9 Duration of androgen deprivation therapy (ADT) with post-operative radiotherapy (RT) for prostate cancer: First results of the RADICALS-HD trial (ISRCTN40814031)

Abstract

There is good evidence on the use of ADT with primary RT as initial treatment for prostate cancer. By contrast, there is uncertainty about the role and duration of ADT with RT after radical prostatectomy (RP).